OpenAlex
PricingAboutJobs
Log inGet started
Work

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

HTML

Year: 2012
Type: article
Study design: Observational Study
Source: Lung Cancer
DOI: 10.1016/j.lungcan.2012.06.005
Authors: Giulio Metro, Rita Chiari, Simona Duranti, Annamaria Siggillino, Matthias J. Fischer, Diana Giannarelli, Vienna Ludovini, Chiara Bennati, Luca Marcomigni, Alice Baldi, Michele Giansanti, Vincenzo Minotti, Lucio Crinò
Institutions: Azienda Ospedaliera di Perugia, Instituto Nazionale Tumori Regina Elena
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: KRAS mutation, EGFR tyrosine kinase inhibitors, gefitinib, erlotinib, advanced non-small cell lung cancer, EGFR wild-type, KRAS codon 12, progression-free survival, overall survival, treatment resistance, predictive biomarkers
SDG: Good health and well-being

Open Access status: closed

Funder: Associazione Italiana per la Ricerca sul Cancro
OpenAlex ID: W2053300543
FWCI: 9.392
Cites: 35
Cited by: 75
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security